SE9401087D0 - New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension - Google Patents
New prostaglandin derivatives for the treatment of glaucoma or ocular hypertensionInfo
- Publication number
- SE9401087D0 SE9401087D0 SE9401087A SE9401087A SE9401087D0 SE 9401087 D0 SE9401087 D0 SE 9401087D0 SE 9401087 A SE9401087 A SE 9401087A SE 9401087 A SE9401087 A SE 9401087A SE 9401087 D0 SE9401087 D0 SE 9401087D0
- Authority
- SE
- Sweden
- Prior art keywords
- glaucoma
- treatment
- ocular hypertension
- prostaglandin derivatives
- new prostaglandin
- Prior art date
Links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9401087A SE9401087D0 (sv) | 1994-03-31 | 1994-03-31 | New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
PCT/SE1995/000347 WO1995026729A1 (en) | 1994-03-31 | 1995-03-31 | New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
AU21559/95A AU2155995A (en) | 1994-03-31 | 1995-03-31 | New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9401087A SE9401087D0 (sv) | 1994-03-31 | 1994-03-31 | New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9401087D0 true SE9401087D0 (sv) | 1994-03-31 |
Family
ID=20393491
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9401087A SE9401087D0 (sv) | 1994-03-31 | 1994-03-31 | New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2155995A (xx) |
SE (1) | SE9401087D0 (xx) |
WO (1) | WO1995026729A1 (xx) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5814660A (en) * | 1995-12-22 | 1998-09-29 | Alcon Laboratories, Inc. | 9-oxa prostaglandin analogs as ocular hypotensives |
US5866602A (en) * | 1995-12-22 | 1999-02-02 | Alcon Laboratories, Inc. | Keto-substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives |
US5994397A (en) * | 1995-12-22 | 1999-11-30 | Alcon Laboratories, Inc. | Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives |
US6353000B1 (en) * | 1996-11-12 | 2002-03-05 | Alcon Laboratories, Inc. | 11-halo prostaglandins for the treatment of glaucoma or ocular hypertension |
SE9900672D0 (sv) * | 1999-02-25 | 1999-02-25 | Synphora Ab | Method and composition for prevention of scar formation in glaucoma filtration bleb and drainage fistula |
US7183310B2 (en) | 2004-08-10 | 2007-02-27 | Allergan, Inc. | Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
AU2006311942B2 (en) | 2005-11-03 | 2012-11-22 | Allergan, Inc. | Prostaglandins and analogues as agents for lowering intraocular pressure |
US8193373B2 (en) | 2006-12-11 | 2012-06-05 | Allergan, Inc. | Therapeutic compounds |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4029693A (en) * | 1975-01-20 | 1977-06-14 | The Upjohn Company | 2A,2B-Dihomo-11-deoxy-17(substituted phenyl)-18,19,20-trinor-PGE2 compounds and their corresponding esters |
US4061670A (en) * | 1976-07-19 | 1977-12-06 | American Cyanamid Company | 15-Deoxy-16-hydroxy-16-vinyl and cyclopropyl substituted prostanoic acids and congeners |
GB1595998A (en) * | 1977-03-30 | 1981-08-19 | American Cyanamid Co | Prostenoic acids and esters |
ES2317964T5 (es) * | 1988-09-06 | 2015-02-20 | Pfizer Health Ab | Derivado de prostaglandina-F2alfa para el tratamiento de glaucoma o hipertensión ocular |
WO1991013869A1 (en) * | 1990-03-08 | 1991-09-19 | Shionogi & Co., Ltd. | 15-deoxyprostaglandin derivative |
-
1994
- 1994-03-31 SE SE9401087A patent/SE9401087D0/xx unknown
-
1995
- 1995-03-31 WO PCT/SE1995/000347 patent/WO1995026729A1/en active Application Filing
- 1995-03-31 AU AU21559/95A patent/AU2155995A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2155995A (en) | 1995-10-23 |
WO1995026729A1 (en) | 1995-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LU91541I2 (fr) | latanoprost et ses dérivés pharmaceutiquement acceptables (XALATAN) | |
DK1514548T3 (da) | Topisk ophthalmisk fluprostenol-præparat til behandling af glaukom og okulær hypertension | |
ES2178291T3 (es) | Uso de acidos 3-benzoil-aceticos, esteres, o amidas para el tratamiento del glaucoma glc1a. | |
MX9702349A (es) | Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma. | |
BRPI0418245A (pt) | nitróxi-derivados de prostaglandina | |
SE8703854D0 (sv) | Prostaglandinderivat for behandling av glaukom eller okuler hypertension | |
MX9400037A (es) | Composicion oftalmica para el tratamiento de glaucoma e hipertension ocular. | |
SE0102055D0 (sv) | New Compounds | |
SE9401087D0 (sv) | New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension | |
ATE326972T1 (de) | Heilende zusammensetzung für intraokulare hypertension oder glaukom | |
NO980058L (no) | Opthalmiske preparater | |
EP0302757A3 (en) | Anti-emetic serotonin depleting agents | |
TR199900013T2 (xx) | Yeni bile�ikler. | |
DE69829227D1 (de) | Arzneimittelzusammenstellung zur behandlung des erhöhten augeninnendrucks oder des glaukom | |
ATE268768T1 (de) | Antithrombosemittel |